These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 3877129

  • 41. Augmentation by OK-432 of generation of culture-induced killer cells.
    Ujiie T.
    Jpn J Exp Med; 1987 Jun; 57(3):153-61. PubMed ID: 3682231
    [Abstract] [Full Text] [Related]

  • 42. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
    Proietti E, Greco G, Garrone B, Baccarini S, Mauri C, Venditti M, Carlei D, Belardelli F.
    J Clin Invest; 1998 Jan 15; 101(2):429-41. PubMed ID: 9435316
    [Abstract] [Full Text] [Related]

  • 43. [Management of malignant ascites with a streptococcal preparation, OK-432: induction of growth inhibition factor(s) against tumor cells].
    Katano M, Yamamoto H, Hisatsugu T.
    Nihon Geka Gakkai Zasshi; 1986 Apr 15; 87(4):471. PubMed ID: 3713694
    [No Abstract] [Full Text] [Related]

  • 44. Immunotherapy of murine and human tumors in mice with lymphokines and interleukin-2-propagated lymphocytes.
    Kedar E, Chriqui-Zeira E, Kyriazis AP.
    J Biol Response Mod; 1984 Oct 15; 3(5):517-26. PubMed ID: 6334139
    [Abstract] [Full Text] [Related]

  • 45. [Treatment of malignant ascites. II. Immunological studies on disappearance of ascites by intraperitoneal injection of a streptococcal preparation, OK-432 (author's transl)].
    Katano M.
    Fukuoka Igaku Zasshi; 1981 Oct 15; 72(10):543-55. PubMed ID: 7327499
    [No Abstract] [Full Text] [Related]

  • 46. Consecutive, multimodal therapy of cancer: selective biological initiation (OK-432), cytoplasmic and nuclear damage (FT-207 and cyclophosphamide), inhibition of repair (bleomycin), and activation of cleansing and surveillance mechanisms.
    Okuyama S, Mishina H.
    Sci Rep Res Inst Tohoku Univ Med; 1981 Dec 15; 28(1-4):7-14. PubMed ID: 6179159
    [No Abstract] [Full Text] [Related]

  • 47. [Induction of activated natural killer cells by the streptococcal preparation OK432 (I). Induction from spleen cells of normal or tumor-bearing mouse primed in vivo and subsequently challenged in vitro with OK432].
    Yamaue H, Tanimura H, Iwahashi M, Tani M, Tsunoda T, Tabuse K.
    Nihon Gan Chiryo Gakkai Shi; 1989 Jul 20; 24(7):1370-8. PubMed ID: 2809371
    [Abstract] [Full Text] [Related]

  • 48. Augmentation of antitumor cytotoxicity in MOPC-315 tumor bearer spleen cells by depletion of glass-adherent cells prior to in vitro activation.
    Mokyr MB, Braun DP, Dray S.
    Cancer Res; 1979 Mar 20; 39(3):785-92. PubMed ID: 427766
    [No Abstract] [Full Text] [Related]

  • 49. The in vivo distribution of transferred syngeneic, allogeneic, and xenogeneic lymphoid cells: implication for the adoptive immunotherapy of tumors.
    Mathisen DJ, Rosenberg SA.
    J Immunol; 1980 May 20; 124(5):2295-300. PubMed ID: 7365258
    [No Abstract] [Full Text] [Related]

  • 50. [Improved therapeutic effect of sequential immunotherapy with cyclophosphamide, large doses of OK-432 and recombinant interleukin-2 in breast cancer patients with disseminated metastatic liver tumors].
    Akimoto M, Nishihira T, Hirakawa H, Abe M, Ohuchi N, Mori S, Kumagai K.
    Nihon Geka Gakkai Zasshi; 1991 Jan 20; 92(1):64-74. PubMed ID: 2014029
    [Abstract] [Full Text] [Related]

  • 51. Production of factor(s) that render polymorphonuclear leukocytes cytostatic from spleen cells stimulated with a streptococcal preparation, OK-432.
    Kimura S, Inoue T, Yamashita T, Midorikawa Y, Arai S, Sendo F.
    Cancer Res; 1987 Dec 01; 47(23):6204-9. PubMed ID: 3315182
    [Abstract] [Full Text] [Related]

  • 52. In vivo kinetics of murine lymphoid cells: in relation to local adoptive cancer immunotherapy.
    Yamasaki N, Kan N, Inamoto T, Nakayama N, Nio Y, Hori T.
    Nihon Geka Hokan; 1984 Jan 01; 53(1):67-78. PubMed ID: 6333856
    [No Abstract] [Full Text] [Related]

  • 53. Effect of polyethylene glycol 6000 on the generation of antitumor cytotoxicity in MOPC-315 tumor bearer spleen cells cultured in the presence or absence of inactivated stimulator tumor cells.
    Przepiorka D, Mokyr MB, Dray S.
    Cancer Res; 1980 Dec 01; 40(12):4565-70. PubMed ID: 7438090
    [Abstract] [Full Text] [Related]

  • 54. Successful adoptive immunotherapy with OK432-inducible activated natural killer cells in tumor-bearing mice.
    Yamaue H, Tanimura H, Iwahashi M, Tsunoda T, Tani M, Inoue M.
    Biotherapy; 1990 Dec 01; 2(1):51-61. PubMed ID: 2400628
    [Abstract] [Full Text] [Related]

  • 55. [Intratumoral administration of OK432 in rats with liver tumor].
    Ishimaru M.
    Nihon Geka Gakkai Zasshi; 1988 Jun 01; 89(6):880-8. PubMed ID: 2972906
    [Abstract] [Full Text] [Related]

  • 56. Effect of streptococcal preparation, OK-432, on experimental infection due to Mycobacterium lepraemurium in mice of C3H/Jms strain.
    Saito H, Tomioka H, Sato K.
    Hiroshima J Med Sci; 1983 Jun 01; 32(2):231-4. PubMed ID: 6352569
    [No Abstract] [Full Text] [Related]

  • 57. [Experimental study of oral administration of streptococcal preparation "OK-432". The 6th report: its effect on in vivo anti-tumor immunity of the mice with transplanted cecal tumor].
    Tsuchitani T, Kodama H, Tobe T, Nio Y, Kan N, Inamoto T, Ohgaki K.
    Nihon Gan Chiryo Gakkai Shi; 1985 Apr 20; 20(3):609-17. PubMed ID: 2932509
    [No Abstract] [Full Text] [Related]

  • 58. [Modulation of anticancer effects of immunochemotherapeutic agents in various nutritional environments].
    Akimoto M, Nishihira T, Mori S.
    Gan To Kagaku Ryoho; 1988 Apr 20; 15(4 Pt 2-1):827-33. PubMed ID: 3260467
    [Abstract] [Full Text] [Related]

  • 59. [Experimental studies on the amplification of anti-tumor effects using bacterial DNA-treated cancer cells, immunoactivators and interferon].
    Kitasato M.
    Nihon Gan Chiryo Gakkai Shi; 1985 Jul 20; 20(6):1107-16. PubMed ID: 3934297
    [No Abstract] [Full Text] [Related]

  • 60. New approach to management of malignant ascites with a streptococcal preparation, OK-432. II. Intraperitoneal inflammatory cell-mediated tumor cell destruction.
    Katano M, Torisu M.
    Surgery; 1983 Mar 20; 93(3):365-73. PubMed ID: 6600854
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.